Industry news

Chinese development group blueprints $1B-plus biotech campus in South San Francisco

John Carroll / ENDPOINTS

When real estate brokers landed the 42-acre waterfront site known as The Landing at Oyster Point in South San Francisco last fall, they oohed and aahed about its potential as a new biotech campus lying adjacent to Genentech, one of the pioneering founders of the industry. It already had a 443,000-square-foot business park in place, with potential for hundreds of thousands of additional space.

Brexit doubts eased as U.K. commits to underwrite R&D grants

Nuala Moran / BioWorld

The U.K. government has moved to end uncertainty about access to European research and development grants following the vote to leave the EU, saying it will underwrite payments on projects that continue beyond the date at which the country finally pulls out

Will biosimilar carve-outs put R&D for older MAbs on ice?

Mari Serebrov / BioWorld

Unintended consequences. It’s a term that’s bandied about all too often in Washington these days, as it’s become the PC way for lawmakers and agencies like the FDA to save face when they have to admit, “Oops, we didn’t think that one through very well” when confronted with the negative impacts of the laws and regulations they’ve created.

In praise of failure

Benedict Evans / Andreessen Horowitz

In most jobs and most industries, if you do something that doesn't work out, that's a bad thing, and you might get fired. If you write a cover story for a newspaper that turns out to be untrue, you have a problem. If you ship a product that breaks, you have a problem.

Russian developers offer new methods to thwart cancer

Marchmont Innovation News

Two Russian tech developers, in Moscow and in Siberia’s Novosibirsk, have independently come up with their own proprietary new solutions to diagnose and treat cancer, Hi-news.ru  reported. 

New “shape memory” exoskeleton underway in Voronezh

Marchmont Innovation News

Andrei Sinegub, a 21-year-old inventor in Voronezh, in Central Russia, is developing a new exoskeleton based on nitinol, a shape memory alloy of nickel and titanium said to possess very useful properties, 3dtoday.ru  reported. 

Survey shows broad support for national precision medicine study

U.S. National Institute of Health

In a recent survey designed to measure public attitudes about the Precision Medicine Initiative (PMI) Cohort Program, a majority of respondents expressed willingness to participate in the nationwide research effort. The findings (link is external) were published online in PLOS ONE by a team of National Institutes of Health researchers.

FCB Health tackles healthcare agency recruiting challenges with 'Bold' campaign

Beth Snyder Bulik / FiercePharmaMarketing

Several years ago, FCB Health surveyed college students on their views of healthcare advertising. One of its starkest findings was that 93% of the students said they would only go into healthcare advertising if they had no other choice.

Integrating Single-Use Systems in Biopharma Manufacturing

Susan Haigney / BioPharm International

Artifacts Images/Getty ImagesTo gain perspective on the use of single-use systems in biopharmaceutical manufacturing,BioPharm International spoke with Nandu Deorkar, PhD, vice-president of Research and Development at Avantor Performance Materials; Steve Miller, global head of Next Generation System Development, Life Science, Upstream and Systems Business Field Millipore S.A.S; Miriam Monge, director of process development and bioprocess platforms, Integrated Solutions at Sartorius Stedim Biotech; and Dr. Chris Chen, CEO of WuXi Biologics. 

PET radiotracer could reveal epigenetic activity in human brain

Alyssa Huntley / FierceBiotech

A team at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH) has found that a PET radiotracer they developed can reveal epigenetic activity within the human brain. The team explained in a report published in Science Translational Medicine that a specific radiochemical called Martinostat can reveal the expression levels of epigenetics-regulating enzymes in the brain.